Cargando…

Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)

BACKGROUND: Alpha amylase inhibitors are used in the treatment of type II diabetes mellitus. Allium sativum and Allium cepa, widely consumed as spices have several medicinal uses which include their traditional use in the management of diabetes. This study was conducted to investigate the alpha amyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Maryam Usman, Ibrahim, Adamu, Dahiru, Noseh Janyo, Mohammed, Hauwa’u Shuaibu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545766/
https://www.ncbi.nlm.nih.gov/pubmed/33088187
http://dx.doi.org/10.1177/1179551420963106
_version_ 1783592096713670656
author Ahmed, Maryam Usman
Ibrahim, Adamu
Dahiru, Noseh Janyo
Mohammed, Hauwa’u Shuaibu
author_facet Ahmed, Maryam Usman
Ibrahim, Adamu
Dahiru, Noseh Janyo
Mohammed, Hauwa’u Shuaibu
author_sort Ahmed, Maryam Usman
collection PubMed
description BACKGROUND: Alpha amylase inhibitors are used in the treatment of type II diabetes mellitus. Allium sativum and Allium cepa, widely consumed as spices have several medicinal uses which include their traditional use in the management of diabetes. This study was conducted to investigate the alpha amylase inhibitory potential and mode of inhibition of A. sativum and A. cepa oils. METHOD: Oil was extracted from dried bulb of A. sativum and A. cepa by Soxhlet extraction. The α-amylase inhibitory potential of the 2 oils were evaluated. The mode of inhibition of the oils were determined from the lineweaver-burk plot and the kinetic parameters obtained from the lineweaver – burk plot. RESULT: A. sativum oil had 58.13 ± 1.09 and 69.8 ± 1.11 percent inhibition at 5.0 and 7.0% concentrations respectively while A. cepa oil had 55.45 ± 1.35, 59.73 ± 1.11 and 65.21 ± 1.11 percent inhibition at 5.0, 7.5 and 10% concentrations respectively. The IC(50) values for A. sativum oil, A. cepa oil and acarbose were 3.0 ± 0.02%, 4.4 ± 0.03% and 14.1 ± 0.09% respectively. The lineweaver – burk plot showed that the Vmax of the 2 oils did not change when compared with that of the no inhibitor (no oil) but the Km increased. CONCLUSION: These findings indicate that A. sativum and A. cepa oils are competitive inhibitors of α- amylase and can both be used in the treatment of type II diabetes mellitus. A. sativum oil is a better inhibitor than A. cepa oil.
format Online
Article
Text
id pubmed-7545766
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75457662020-10-20 Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion) Ahmed, Maryam Usman Ibrahim, Adamu Dahiru, Noseh Janyo Mohammed, Hauwa’u Shuaibu Clin Med Insights Endocrinol Diabetes Original Article BACKGROUND: Alpha amylase inhibitors are used in the treatment of type II diabetes mellitus. Allium sativum and Allium cepa, widely consumed as spices have several medicinal uses which include their traditional use in the management of diabetes. This study was conducted to investigate the alpha amylase inhibitory potential and mode of inhibition of A. sativum and A. cepa oils. METHOD: Oil was extracted from dried bulb of A. sativum and A. cepa by Soxhlet extraction. The α-amylase inhibitory potential of the 2 oils were evaluated. The mode of inhibition of the oils were determined from the lineweaver-burk plot and the kinetic parameters obtained from the lineweaver – burk plot. RESULT: A. sativum oil had 58.13 ± 1.09 and 69.8 ± 1.11 percent inhibition at 5.0 and 7.0% concentrations respectively while A. cepa oil had 55.45 ± 1.35, 59.73 ± 1.11 and 65.21 ± 1.11 percent inhibition at 5.0, 7.5 and 10% concentrations respectively. The IC(50) values for A. sativum oil, A. cepa oil and acarbose were 3.0 ± 0.02%, 4.4 ± 0.03% and 14.1 ± 0.09% respectively. The lineweaver – burk plot showed that the Vmax of the 2 oils did not change when compared with that of the no inhibitor (no oil) but the Km increased. CONCLUSION: These findings indicate that A. sativum and A. cepa oils are competitive inhibitors of α- amylase and can both be used in the treatment of type II diabetes mellitus. A. sativum oil is a better inhibitor than A. cepa oil. SAGE Publications 2020-10-07 /pmc/articles/PMC7545766/ /pubmed/33088187 http://dx.doi.org/10.1177/1179551420963106 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Ahmed, Maryam Usman
Ibrahim, Adamu
Dahiru, Noseh Janyo
Mohammed, Hauwa’u Shuaibu
Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)
title Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)
title_full Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)
title_fullStr Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)
title_full_unstemmed Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)
title_short Alpha Amylase Inhibitory Potential and Mode of Inhibition of Oils from Allium sativum (Garlic) and Allium cepa (Onion)
title_sort alpha amylase inhibitory potential and mode of inhibition of oils from allium sativum (garlic) and allium cepa (onion)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545766/
https://www.ncbi.nlm.nih.gov/pubmed/33088187
http://dx.doi.org/10.1177/1179551420963106
work_keys_str_mv AT ahmedmaryamusman alphaamylaseinhibitorypotentialandmodeofinhibitionofoilsfromalliumsativumgarlicandalliumcepaonion
AT ibrahimadamu alphaamylaseinhibitorypotentialandmodeofinhibitionofoilsfromalliumsativumgarlicandalliumcepaonion
AT dahirunosehjanyo alphaamylaseinhibitorypotentialandmodeofinhibitionofoilsfromalliumsativumgarlicandalliumcepaonion
AT mohammedhauwaushuaibu alphaamylaseinhibitorypotentialandmodeofinhibitionofoilsfromalliumsativumgarlicandalliumcepaonion